Medicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.
Even if they're not acquired, these small companies are developing promising obesity ... add up to a nice investment opportunity. First, corporate buyouts are back in style. Second, weight-loss ...
WASHINGTON — About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... application to add cardiovascular benefits to the medicine’s label. GLP-1 medications such ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
2023 Novo Invests $2.3 Billion in France for Obesity Drug Production Novo Nordisk has announced a $2.3 billion investment to boost production of its wildly popular weight-loss and diabetes drugs ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...